These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16047197)

  • 21. [Therapy strategies for advanced renal cell carcinoma].
    Staehler M; Haseke N; Schöppler G; Stadler T; Adam C; Stief CG
    Urologe A; 2006 Jan; 45(1):99-110, quiz 111-2. PubMed ID: 16372186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Brain metastases in cases of renal cell carcinoma].
    Buse S; Bedke J; Kurosch M; Haferkamp A; Unterberg A; Herfarth K; Hohenfellner M
    Urologe A; 2007 Jan; 46(1):36-9. PubMed ID: 17186191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urological cancer: towards rational post-nephrectomy follow-up guidelines in RCC.
    Patard JJ; Escudier B
    Nat Rev Clin Oncol; 2015 Mar; 12(3):131-2. PubMed ID: 25668729
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal cell carcinoma: what the surgeon and treating physician need to know.
    Chapin BF; Delacroix SE; Wood CG
    AJR Am J Roentgenol; 2011 Jun; 196(6):1255-62. PubMed ID: 21606286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical recommendations for treating and monitoring patients with renal cancer].
    Petković M; Vrdoljak E; Ruzić IP; Belev B; Omrcen T; Ledina D; Tomek R; Ruzić B; Situm M; Buća A; Pisac VP;
    Lijec Vjesn; 2012; 134(1-2):5-8. PubMed ID: 22519246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Escudier B; Porta C; Schmidinger M; Algaba F; Patard JJ; Khoo V; Eisen T; Horwich A;
    Ann Oncol; 2014 Sep; 25 Suppl 3():iii49-56. PubMed ID: 25210086
    [No Abstract]   [Full Text] [Related]  

  • 27. [Secondary prevention after urological tumor diseases. Focusing on the kidneys, testes, and bladder].
    Mathers MJ; Lazica DA; Klotz T; Sommer F; Roth S
    Urologe A; 2007 Jun; 46(6):636-41. PubMed ID: 17487469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal cell carcinoma: diagnosis, staging, and surveillance.
    Ng CS; Wood CG; Silverman PM; Tannir NM; Tamboli P; Sandler CM
    AJR Am J Roentgenol; 2008 Oct; 191(4):1220-32. PubMed ID: 18806169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant and neoadjuvant therapies in high-risk renal cell carcinoma.
    Smaldone MC; Fung C; Uzzo RG; Haas NB
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):765-91. PubMed ID: 21763967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Not Available].
    Aktuelle Urol; 2015 Nov; 46(6):430. PubMed ID: 26599942
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Escudier B; Porta C; Schmidinger M; Rioux-Leclercq N; Bex A; Khoo V; Gruenvald V; Horwich A;
    Ann Oncol; 2016 Sep; 27(suppl 5):v58-v68. PubMed ID: 27664262
    [No Abstract]   [Full Text] [Related]  

  • 32. [After-care and palliative therapeutic measures in ovarian carcinoma].
    Kurz C; Vavra N; Sevelda P
    Wien Med Wochenschr; 1996; 146(1-2):34-7. PubMed ID: 8835493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chromophobe renal cell carcinoma - case report].
    Krawiec K; Marks P; Różański W; Lipiński M
    Pol Merkur Lekarski; 2015 Feb; 38(224):100-3. PubMed ID: 25771519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Renal Cell Carcinoma Surveillance Guidelines: Competing Trade-Offs.
    Lobo JM; Nelson M; Nandanan N; Krupski TL
    J Urol; 2016 Jun; 195(6):1664-70. PubMed ID: 26778713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up of the melanoma patient.
    Deschner B; Wayne JD
    J Surg Oncol; 2019 Jan; 119(2):262-268. PubMed ID: 30548539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor after-care: goals, results and concepts].
    Haas I
    Laryngorhinootologie; 2000 Nov; 79(11):667-8. PubMed ID: 11138508
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal cell carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Escudier B; Kataja V;
    Ann Oncol; 2009 May; 20 Suppl 4():81-2. PubMed ID: 19454473
    [No Abstract]   [Full Text] [Related]  

  • 38. [Guideline 'Renal cell carcinoma'].
    Mulders PF; Brouwers AH; Hulsbergen-van der Kaa CA; van Lin EN; Osanto S; de Mulder PH
    Ned Tijdschr Geneeskd; 2008 Feb; 152(7):376-80. PubMed ID: 18380384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follow-up of renal cell carcinoma. American College of Radiology. ACR Appropriateness Criteria.
    Newhouse JH; Amis ES; Bigongiari LR; Bluth EI; Bush WH; Choyke PL; Fritzsche PJ; Holder LE; Sandler CM; Segal AJ; Resnick MI; Rutsky EA
    Radiology; 2000 Jun; 215 Suppl():761-4. PubMed ID: 11037497
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of the Incidental Kidney Mass in the Nephrology Clinic.
    Hu SL; Weiss RH
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1407-1409. PubMed ID: 29653957
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.